Assessing the Use of Mobile Technology in Adult Asthma Patients

Assessing the Use of Digital Therapeutic in Adult Asthma Patients: A Remote Observational Study

This is a prospective, remote observational study of adults with persistent asthma who are managed on inhaled corticosteroids.

The study consists of one interventional group and all 104 subjects will be included in this group. All subjects will be provided with the HeroTracker package, which includes:

1. HeroTracker sensor that counts dosage and monitors real-time medication adherence
2. BreatheSmart mobile application that sends subjects real-time alerts and allows patients respond to questionnaires / surveys.

Inclusion Criteria:

• Ability to provide written informed consent
• Male and female adults (aged ≥ 18 years)
• Diagnosis of asthma for at least 6 months
• ICS (inhaled corticosteroid) use for at least 3 months
• Use of a pressurized metered dose inhaler (pMDI) compatible with the HeroTracker
• Possess a compatible smartphone (iOS 8.0 or higher and Android 4.3 or higher)

Exclusion Criteria:

• Currently pregnant or planning to become pregnant during the study period
• Primary language other than English (BreatheSmart mobile app is currently available only in English)